[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-[2-(6-methoxynaphthalen-2-yl)ethyl]piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-1-ylethyl)piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-2-ylethyl)piperazin-1-yl]methanone

C127H155N15O4 — CID 157349924

IUPAC[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-[2-(6-methoxynaphthalen-2-yl)ethyl]piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-1-ylethyl)piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-2-ylethyl)piperazin-1-yl]methanone
SMILESCOc1ccc2cc(CCN3CCN(C(=O)c4ccc(Cc5ccc6c(c5)c(C)c(C)n6CCCN5CCN(C)CC5)cc4)CC3)ccc2c1.Cc1c(C)n(CCCN2CCN(C)CC2)c2ccc(Cc3ccc(C(=O)N4CCN(CCc5ccc6ccccc6c5)CC4)cc3)cc12.Cc1c(C)n(CCCN2CCN(C)CC2)c2ccc(Cc3ccc(C(=O)N4CCN(CCc5cccc6ccccc56)CC4)cc3)cc12
InChIInChI=1S/C43H53N5O2.2C42H51N5O/c1-32-33(2)48(18-5-17-45-22-20-44(3)21-23-45)42-15-9-36(30-41(32)42)28-34-6-10-37(11-7-34)43(49)47-26-24-46(25-27-47)19-16-35-8-12-39-31-40(50-4)14-13-38(39)29-35;1-32-33(2)47(20-7-19-44-24-22-43(3)23-25-44)41-17-14-35(31-40(32)41)30-34-12-15-38(16-13-34)42(48)46-28-26-45(27-29-46)21-18-37-10-6-9-36-8-4-5-11-39(36)37;1-32-33(2)47(19-6-18-44-23-21-43(3)22-24-44)41-16-12-36(31-40(32)41)29-34-10-14-38(15-11-34)42(48)46-27-25-45(26-28-46)20-17-35-9-13-37-7-4-5-8-39(37)30-35/h6-15,29-31H,5,16-28H2,1-4H3;4-6,8-17,31H,7,18-30H2,1-3H3;4-5,7-16,30-31H,6,17-29H2,1-3H3
InChIKeyBHKHILHOKNIQIA-UHFFFAOYSA-N
MW1955.74 g/mol
LogP19.93
Rot. Bonds31

About [4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-[2-(6-methoxynaphthalen-2-yl)ethyl]piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-1-ylethyl)piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-2-ylethyl)piperazin-1-yl]methanone

[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-[2-(6-methoxynaphthalen-2-yl)ethyl]piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-1-ylethyl)piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-2-ylethyl)piperazin-1-yl]methanone (PubChem CID 157349924) has the molecular formula C127H155N15O4 and a molecular weight of 1955.74 g/mol. Its IUPAC name is [4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-[2-(6-methoxynaphthalen-2-yl)ethyl]piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-1-ylethyl)piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-2-ylethyl)piperazin-1-yl]methanone.

Molecular Properties

Compound Name[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-[2-(6-methoxynaphthalen-2-yl)ethyl]piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-1-ylethyl)piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-2-ylethyl)piperazin-1-yl]methanone
PubChem CID157349924
Molecular FormulaC127H155N15O4
Molecular Weight1955.74 g/mol
Exact Mass1954.24
IUPAC Name[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-[2-(6-methoxynaphthalen-2-yl)ethyl]piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-1-ylethyl)piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-2-ylethyl)piperazin-1-yl]methanone
SMILESCOc1ccc2cc(CCN3CCN(C(=O)c4ccc(Cc5ccc6c(c5)c(C)c(C)n6CCCN5CCN(C)CC5)cc4)CC3)ccc2c1.Cc1c(C)n(CCCN2CCN(C)CC2)c2ccc(Cc3ccc(C(=O)N4CCN(CCc5ccc6ccccc6c5)CC4)cc3)cc12.Cc1c(C)n(CCCN2CCN(C)CC2)c2ccc(Cc3ccc(C(=O)N4CCN(CCc5cccc6ccccc56)CC4)cc3)cc12
InChIInChI=1S/C43H53N5O2.2C42H51N5O/c1-32-33(2)48(18-5-17-45-22-20-44(3)21-23-45)42-15-9-36(30-41(32)42)28-34-6-10-37(11-7-34)43(49)47-26-24-46(25-27-47)19-16-35-8-12-39-31-40(50-4)14-13-38(39)29-35;1-32-33(2)47(20-7-19-44-24-22-43(3)23-25-44)41-17-14-35(31-40(32)41)30-34-12-15-38(16-13-34)42(48)46-28-26-45(27-29-46)21-18-37-10-6-9-36-8-4-5-11-39(36)37;1-32-33(2)47(19-6-18-44-23-21-43(3)22-24-44)41-16-12-36(31-40(32)41)29-34-10-14-38(15-11-34)42(48)46-27-25-45(26-28-46)20-17-35-9-13-37-7-4-5-8-39(37)30-35/h6-15,29-31H,5,16-28H2,1-4H3;4-6,8-17,31H,7,18-30H2,1-3H3;4-5,7-16,30-31H,6,17-29H2,1-3H3
InChIKeyBHKHILHOKNIQIA-UHFFFAOYSA-N
XLogP19.93
TPSA114.11 Ų
H-Bond Donors
H-Bond Acceptors16
Rotatable Bonds31
Heavy Atoms146
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001955.74
LogP ≤ 519.93
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}

Analyze [4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-[2-(6-methoxynaphthalen-2-yl)ethyl]piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-1-ylethyl)piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-2-ylethyl)piperazin-1-yl]methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-[2-(6-methoxynaphthalen-2-yl)ethyl]piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-1-ylethyl)piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-2-ylethyl)piperazin-1-yl]methanone?
The IUPAC name of [4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-[2-(6-methoxynaphthalen-2-yl)ethyl]piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-1-ylethyl)piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-2-ylethyl)piperazin-1-yl]methanone (CID 157349924) is [4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-[2-(6-methoxynaphthalen-2-yl)ethyl]piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-1-ylethyl)piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-2-ylethyl)piperazin-1-yl]methanone.
What is the SMILES notation for [4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-[2-(6-methoxynaphthalen-2-yl)ethyl]piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-1-ylethyl)piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-2-ylethyl)piperazin-1-yl]methanone?
The canonical SMILES for [4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-[2-(6-methoxynaphthalen-2-yl)ethyl]piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-1-ylethyl)piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-2-ylethyl)piperazin-1-yl]methanone is COc1ccc2cc(CCN3CCN(C(=O)c4ccc(Cc5ccc6c(c5)c(C)c(C)n6CCCN5CCN(C)CC5)cc4)CC3)ccc2c1.Cc1c(C)n(CCCN2CCN(C)CC2)c2ccc(Cc3ccc(C(=O)N4CCN(CCc5ccc6ccccc6c5)CC4)cc3)cc12.Cc1c(C)n(CCCN2CCN(C)CC2)c2ccc(Cc3ccc(C(=O)N4CCN(CCc5cccc6ccccc56)CC4)cc3)cc12.
What is the InChIKey of [4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-[2-(6-methoxynaphthalen-2-yl)ethyl]piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-1-ylethyl)piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-2-ylethyl)piperazin-1-yl]methanone?
The InChIKey is BHKHILHOKNIQIA-UHFFFAOYSA-N. The full InChI is InChI=1S/C43H53N5O2.2C42H51N5O/c1-32-33(2)48(18-5-17-45-22-20-44(3)21-23-45)42-15-9-36(30-41(32)42)28-34-6-10-37(11-7-34)43(49)47-26-24-46(25-27-47)19-16-35-8-12-39-31-40(50-4)14-13-38(39)29-35;1-32-33(2)47(20-7-19-44-24-22-43(3)23-25-44)41-17-14-35(31-40(32)41)30-34-12-15-38(16-13-34)42(48)46-28-26-45(27-29-46)21-18-37-10-6-9-36-8-4-5-11-39(36)37;1-32-33(2)47(19-6-18-44-23-21-43(3)22-24-44)41-16-12-36(31-40(32)41)29-34-10-14-38(15-11-34)42(48)46-27-25-45(26-28-46)20-17-35-9-13-37-7-4-5-8-39(37)30-35/h6-15,29-31H,5,16-28H2,1-4H3;4-6,8-17,31H,7,18-30H2,1-3H3;4-5,7-16,30-31H,6,17-29H2,1-3H3.
What are the key properties of [4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-[2-(6-methoxynaphthalen-2-yl)ethyl]piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-1-ylethyl)piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-2-ylethyl)piperazin-1-yl]methanone?
[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-[2-(6-methoxynaphthalen-2-yl)ethyl]piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-1-ylethyl)piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-2-ylethyl)piperazin-1-yl]methanone has a molecular weight of 1955.74 g/mol, XLogP of 19.93, 31 rotatable bonds, 0 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-[2-(6-methoxynaphthalen-2-yl)ethyl]piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-1-ylethyl)piperazin-1-yl]methanone;[4-[[2,3-dimethyl-1-[3-(4-methylpiperazin-1-yl)propyl]indol-5-yl]methyl]phenyl]-[4-(2-naphthalen-2-ylethyl)piperazin-1-yl]methanone is sourced from PubChem (CID 157349924), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).